**RNA Editing: Emerging from CRISPR’s Shadow**
RNA editing technology is stepping out from the shadow of CRISPR gene editing. Recent developments, such as the early data from Wave Life Sciences, demonstrate the potential of RNA editing to develop effective therapies. These advancements indicate just the beginning of a growing interest among large and small biotech firms.
RNA editing holds promise due to its ability to make precise changes to RNA sequences, potentially fixing genetic errors at a post-transcriptional level. This precision may offer advantages over DNA-targeting technologies like CRISPR, as it reduces the risk of off-target effects and permanent genomic changes.
Wave Life Sciences, a notable player in this space, has presented encouraging early data. The results suggest that RNA editing can indeed produce viable medicines, sparking interest from industry giants and nimble biotech startups alike. Their work illustrates RNA editing’s potential